Shares of Merit Medical Systems, Inc. (NASDAQ:MMSI) have been assigned a consensus recommendation of “Buy” from the fourteen ratings firms that are presently covering the stock, Marketbeat Ratings reports. One analyst has rated the stock with a sell rating, two have assigned a hold rating and eleven have given a buy rating to the company. The average 12-month price target among brokerages that have issued ratings on the stock in the last year is $43.77.

Several equities analysts recently issued reports on the company. ValuEngine lowered Merit Medical Systems from a “buy” rating to a “hold” rating in a research note on Friday, December 1st. BidaskClub lowered Merit Medical Systems from a “hold” rating to a “sell” rating in a research note on Tuesday, December 5th. Canaccord Genuity restated a “buy” rating and set a $45.00 price target on shares of Merit Medical Systems in a research note on Sunday, October 8th. Raymond James Financial restated an “outperform” rating and set a $44.00 price target on shares of Merit Medical Systems in a research note on Monday, August 28th. Finally, UBS lowered Merit Medical Systems from a “strong-buy” rating to an “outperform” rating in a research note on Monday, August 28th.

Merit Medical Systems (MMSI) opened at $44.90 on Friday. Merit Medical Systems has a 12 month low of $24.23 and a 12 month high of $45.50. The company has a debt-to-equity ratio of 0.39, a quick ratio of 1.43 and a current ratio of 2.78. The stock has a market capitalization of $2,183.65, a PE ratio of 34.25, a P/E/G ratio of 2.95 and a beta of 1.23.

Merit Medical Systems (NASDAQ:MMSI) last issued its quarterly earnings results on Wednesday, October 25th. The medical instruments supplier reported $0.32 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.30 by $0.02. Merit Medical Systems had a return on equity of 9.86% and a net margin of 4.06%. The firm had revenue of $179.30 million for the quarter, compared to analyst estimates of $181.28 million. During the same period in the previous year, the company posted $0.26 earnings per share. The company’s quarterly revenue was up 14.2% compared to the same quarter last year. equities analysts anticipate that Merit Medical Systems will post 1.27 EPS for the current fiscal year.

In other Merit Medical Systems news, Director Kent W. Stanger sold 2,918 shares of Merit Medical Systems stock in a transaction that occurred on Thursday, November 30th. The stock was sold at an average price of $44.55, for a total transaction of $129,996.90. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. 5.00% of the stock is currently owned by insiders.

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Wolverine Trading LLC acquired a new stake in Merit Medical Systems during the third quarter valued at approximately $226,000. Insight Capital Research & Management Inc. acquired a new stake in Merit Medical Systems during the third quarter valued at approximately $1,258,000. Neuberger Berman Group LLC boosted its holdings in Merit Medical Systems by 1,420.2% during the third quarter. Neuberger Berman Group LLC now owns 304,049 shares of the medical instruments supplier’s stock valued at $12,876,000 after purchasing an additional 284,049 shares in the last quarter. California Public Employees Retirement System boosted its holdings in Merit Medical Systems by 5.9% during the third quarter. California Public Employees Retirement System now owns 142,092 shares of the medical instruments supplier’s stock valued at $6,018,000 after purchasing an additional 7,892 shares in the last quarter. Finally, Point72 Asset Management L.P. acquired a new stake in Merit Medical Systems during the third quarter valued at approximately $8,889,000. 90.89% of the stock is currently owned by institutional investors.

TRADEMARK VIOLATION NOTICE: “Merit Medical Systems, Inc. (MMSI) Receives Average Rating of “Buy” from Brokerages” was originally reported by American Banking News and is owned by of American Banking News. If you are accessing this article on another publication, it was illegally copied and reposted in violation of U.S. and international trademark & copyright laws. The legal version of this article can be accessed at https://www.americanbankingnews.com/2017/12/16/merit-medical-systems-inc-mmsi-receives-average-rating-of-buy-from-brokerages.html.

About Merit Medical Systems

Merit Medical Systems, Inc is a manufacturer and marketer of disposable medical devices used in a range of interventional, diagnostic and therapeutic medical procedures. The Company operates in two segments: cardiovascular and endoscopy. The cardiovascular segment consists of cardiology and radiology devices, which assist in diagnosing and treating coronary arterial disease, peripheral vascular disease and other non-vascular diseases, and includes embolotherapeutic, cardiac rhythm management (CRM), electrophysiology (EP), and interventional oncology and spine devices.

Analyst Recommendations for Merit Medical Systems (NASDAQ:MMSI)

Receive News & Ratings for Merit Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merit Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.